Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Supplementary MaterialMaterials and Methods
Cell preparation and transfer: Bone marrow cells from B10.A mice were cultured for 7 days in GM-CSF (5 ng/ml) and IL-4 (10 ng/ml) (1). Cells recovered from these cultures were generally 80 - 90% CD11c+. The CD11c+ BMDC were MHC class IImed-hi, CD80med, CD86low-med, CD40neg. These BMDC were either left antigen-free or pulsed for 12 hrs with 3
Lymph node preparation and imaging: The draining popliteal lymph node was removed at the indicated time after T-cell i.v. transfer, which followed the s.c. injection of antigen-free or antigen-bearing DC by 18-37 hrs. as indicated in each figure or supplemental movie. Preliminary experiments confirmed that the transferred T-cells homed to the expected locations within lymph nodes (Fig. S1), but unexpectedly revealed that simultaneous administration of T-cells and antigen-bearing, but not antigen-free, DC retarded arrival of the DC in the lymph node (2). For this reason, DC were given 6-12 hrs. prior to the T-cells in all the experiments reported here. A lymph node containing transferred T-cells and DC was trimmed free of fat, placed in a heated chamber (delta T dish, Bioptechs, Inc., Butler, PA), and fixed in place with partially cooled 2.5% agarose. The dish was then placed into the stage adapter on the microscope, filled with 200 Cell migration tracking: Individual T-cells were tracked over a 3 hr interval, plotting their position every 3 min. when a new image was acquired. The mean distance traversed was determined from these plotted migration paths, the known image magnification, and a reticule scale. This was divided by the total time of the recording, yielding mean velocity.
Preparation and imaging of naïve T-cells expressing CD43-GFP: 5C.C7 T-cells activated and then infected in vitro as reported (6) did not show appreciable accumulation in the draining lymph node, as expected from the loss of CD62L and, presumably, CCR7 expression. Therefore, a variation of the method of Hollander et al. (7) was employed to generate naïve CD43-GFP+ T-cells that would home to LN. 5C.C7 x RAG-2-/- TCR transgenic mice were treated with 150 mg/kg 5-fluoruracil to mobilize bone marrow stem cells. Three days after drug treatment, bone marrow was harvested from the long bones and subjected to 6 rounds of spin infection using MSCV-CD43-GFP retrovirus as previously described for in vitro T-cell infection (6, 7). The infected bone marrow cells were transferred i.v. into sublethally irradiated (700 rad) B10.A mice. After 7 weeks, LN and spleen cells were harvested to provide a lymphocyte population consisting in large measure of CD43-GFP+ CD4+ 5C.C7 T-cells. These cells were labeled with SNARF and injected into B10.A mice that had been injected s.c. in the footpad 12 hrs previously with 1.5x106 BMDC pulsed for 12 hrs with 3
Supplemental Figure 1. Frozen sections of lymph node were prepared 18 hrs after injection of CFSE-labeled T-cells (green) and SNARF-labeled BMDC (red) into syngeneic animals. The sections were stained for CD19 (blue) (A) or for CD3
Medium version | Full size version
Supplemental Figure 2. CD69 expression by CFSE+ T-cells recovered from imaged lymph nodes similar to those employed in Text Figure 1A and B and containing antigen-unpulsed (blue open histogram) or antigen-pulsed (red closed histogram) DC.
Medium version | Full size version
Note S1: The number of BMDC in the lymph node studied is similar to that found in the presence of an infectious / dangerous stimulus. In previous work, as many as 104 additional CD11c+ cells were found in the lymph node draining the site of skin bombardment with gold particles using a gene gun (8), which is an accepted vaccination strategy. Similar increases have been seen using systemic LPS or STAg inflammatory stimuli (9, 10). Others have shown that the number of Langerhans cells that migrate to a lymph node after skin painting with a contact sensitizer is similar to the number of BMDC arriving in the lymph nodes examined here and these LC have a similar surface phenotype to the BMDC at the time of transfer (MHC class II++, CD40-, CD80+, CD86low). The number of DC transferred has also been varied and no differences from the results reported seen with as few as 0.3x106 injected DC. Note S2: While single photon imaging causes more photodamage than multiphoton imaging under otherwise similar conditions, such cell damage is unlikely to be the origin of the cell behavior reported here. With LN removed both early and late after T-cell transfer, the imaging involved the same instruments, laser settings, and time of exposure. Thus, phototoxicity should be similar in both cases, even though cell migration was much greater in the latter situation. In addition, no apparent decrement in cell mobility was seen after several hours of imaging with LN taken more than 37 hrs. after T-cell transfer into animals given containing antigen-bearing DC. Note S3: Experiments were also conducted in which just T-cells but no DC were transferred. Under these conditions, no movement of the T-cells is seen at early or late times after transfer, in contrast to the results with antigen-bearing DC. This makes it very unlikely that the BMDC desensitize the T-cells by secreting excess chemokine, given that there is a gain in migratory activity following introduction of these cells with bound antigen. Finally, BMDC make high levels of SLC and ELC, but this is also true for DC activated in vivo and secretion of these mediators is key to attracting T-cells to DC for scanning of displayed antigen. Whether even higher levels are achieved using the transferred cells as compared to inflammatory stimuli applied in situ is unknown. In any case, excess chemokine signaling is unlikely to have accounted for the lack of T-cell migration in lymph nodes removed at early times after T-cell transfer. Migration was seen only when antigen was present, although chemokine production should have been the same with pulsed versus unpulsed BMDC. In addition, high levels of SLC overcome the stop signal imposed by antigen recognition (11), so the effect of excess chemokine production should be greater not less migration in the presence of antigen, the opposite of what was observed. Direct measurements have shown lymphoid tissues to have low oxygen tension under in vivo physiological conditions (12); it is actually of a concern that in room air, oxygenation may be greater than normal, especially at the more superficial areas of the lymph node. The first widely employed in vitro system for generating immune responses (13) used a gas mixture with 7%O2 and the reducing agent 2-ME is typically added to lymphocyte culture medium when this work is performed at normal 20% O2. T-cells move well when recordings involve lymph nodes removed late after cell transfer as compared to early, even though both have the same conditions of oxygenation; furthermore, experiments using SNARF, a pH sensitive dye, do not show a change in pH within the T cells during the recording periods employed here. It is therefore unclear whether attempts to enhance oxygenation are in fact more or less likely to give conditions that best reflect the in vivo state. The obvious solution is to do the microscopy under intravital conditions with normal blood flow. However, it is extraordinarily difficult to make recordings at high resolution over prolonged times with exteriorized lymph nodes of living, breathing animals. Thus, it will be necessary to combine judicious use of short-term experiments under intravital conditions with long-term tracking studies in an explant model such as the one employed here so that a more complete view of lymphocyte behavior can be achieved.
Note S4: Exclusion of CD43 can be also occasionally be observed in the region of contact of T-cells with transferred unpulsed DC and even with what appear to be host DC. Therefore, it seems that the exclusion of CD43 is not strictly foreign-antigen dependent. However, T-cells make productive interactions with self-MHC molecules in vivo, as shown with respect to maintenance of partial TCR Note S5: Although the lymph node preparations imaged here lack blood and lymph flow, as well as signals from nerves, the time at which CD69 elevation is seen, at which cell division is seen, and at which dissociation and movement of T-cells away from antigen bearing DC is seen matches results obtained in completely in vivo models. CSFE labeled naïve TCR transgenic T-cells first show evidence of cell division at approximately 36 hrs after antigen exposure begins in vivo (18); likewise, CSFE-labeled cells are sequestered from the blood stream for 48 hrs in the presence of antigen.
1. K. Inaba et al., J. Exp. Med. 176, 1693 (1992). 2. S. Stoll, unpublished observations. 3. R. A. Seder, W. E. Paul, Annu. Rev. Immunol. 12, 635 (1994). 4. Y. Shinkai et al., Cell 68, 855 (1992). 5. E. Ingulli, A. Mondino, A. Khoruts, M. K. Jenkins, J. Exp. Med. 185, 2133 (1997). 6. J. Delon, K. Kaibuchi, R. N. Germain, Immunity 15, 691 (2001). 7. G. A. Hollander, B. D. Luskey, D. A. Williams, S. J. Burakoff, J. Immunol. 149, 438 (1992). 8. A. Porgador et al., J. Exp. Med. 188, 1075 (1998). 9. C. Reis e Sousa et al., J. Exp. Med. 186, 1819 (1997). 10. C. Reis e Sousa, R. N. Germain, J. Immunol. 162, 6552 (1999). 11. S. K. Bromley, D. A. Peterson, M. D. Gunn, M. L. Dustin, J. Immunol. 165, 15 (2000). 12. C. C. Caldwell et al., J. Immunol. 167, 6140 (2001). 13. R. I. Mishell, R. W. Dutton, J. Exp. Med. 126, 423 (1967). 14. J. R. Dorfman, I. Stefanova, K. Yasutomo, R. N. Germain, Nature Immunol. 1, 329 (2000). 15. D. Witherden et al., J. Exp. Med. 191, 355 (2000). 16. P. Révy, M. Sospedra, B. Barbour, A. Trautmann, Nature Immunol. 2, 925 (2001). 17. J. M. Serrador et al., Blood 91, 4632 (1998). 18. C. Tanchot, D. L. Barber, L. Chiodetti, R. H. Schwartz, J. Immunol. 167, 2030 (2001).
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)